Abstract
Thrombin induces platelet aggregation and formation of a fibrin clot in platelet-rich plasma; leupeptin, a protease inhibitor, partially inhibits platelet aggregation, but it does not inhibit fibrin clot formation. Indomethacin does not inhibit either thrombin-induced platelet aggregation or fibrin clot formation. However, when the two drugs are given together, a synergistic inhibition of thrombin-induced platelet aggregation occurs, while fibrin clot formation remains unaffected. Thrombin-induced stimulation of the release of serotonin in washed human platelets is also synergistically inhibited by the combined actions of leupeptin and indomethacin. Thrombin and collagen, added simultaneously, induce full platelet aggregation and release of serotonin. Neither leupeptin nor indomethacin inhibits platelet responses elicited by both agonists; however, when leupeptin and indomethacin are given together, a synergistic inhibition of thrombin- and collagen-induced response is observed. These findings might be relevant in prophylaxis and treatment of thromboembolic disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aoki N., Naito K., Yoshida N. Inhibition of platelet aggregation by protease inhibitors. Possible involvement of proteases in platelet aggregation. Blood. 1978 Jul;52(1):1–12. [PubMed] [Google Scholar]
- Baldassare J. J., Bakshian S., Knipp M. A., Fisher G. J. Inhibition of fibrinogen receptor expression and serotonin release by leupeptin and antipain. J Biol Chem. 1985 Sep 5;260(19):10531–10535. [PubMed] [Google Scholar]
- Breddin K., Loew D., Lechner K., Uberla K., Walter E. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study. Thromb Haemost. 1979 Feb 28;41(1):225–236. [PubMed] [Google Scholar]
- Fox J. E., Goll D. E., Reynolds C. C., Phillips D. R. Identification of two proteins (actin-binding protein and P235) that are hydrolyzed by endogenous Ca2+-dependent protease during platelet aggregation. J Biol Chem. 1985 Jan 25;260(2):1060–1066. [PubMed] [Google Scholar]
- Fox J. E., Reynolds C. C., Phillips D. R. Calcium-dependent proteolysis occurs during platelet aggregation. J Biol Chem. 1983 Aug 25;258(16):9973–9981. [PubMed] [Google Scholar]
- Melloni E., Pontremoli S., Michetti M., Sacco O., Sparatore B., Salamino F., Horecker B. L. Binding of protein kinase C to neutrophil membranes in the presence of Ca2+ and its activation by a Ca2+-requiring proteinase. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6435–6439. doi: 10.1073/pnas.82.19.6435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mustard J. F., Kinlough-Rathbone R. L., Packham M. A. Aspirin in the treatment of cardiovascular disease: a review. Am J Med. 1983 Jun 14;74(6A):43–49. doi: 10.1016/0002-9343(83)90527-2. [DOI] [PubMed] [Google Scholar]
- O'Halloran T., Beckerle M. C., Burridge K. Identification of talin as a major cytoplasmic protein implicated in platelet activation. Nature. 1985 Oct 3;317(6036):449–451. doi: 10.1038/317449a0. [DOI] [PubMed] [Google Scholar]
- Phillips D. R., Jakábová M. Ca2+-dependent protease in human platelets. Specific cleavage of platelet polypeptides in the presence of added Ca2+. J Biol Chem. 1977 Aug 25;252(16):5602–5605. [PubMed] [Google Scholar]
- Ruggiero M., Lapetina E. G. Leupeptin selectively inhibits human platelet responses induced by thrombin and trypsin; a role for proteolytic activation of phospholipase C. Biochem Biophys Res Commun. 1985 Sep 30;131(3):1198–1205. doi: 10.1016/0006-291x(85)90218-9. [DOI] [PubMed] [Google Scholar]